|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Neuropathy due to type 2 diabetes mellitus | 16-Aug-2024 | active |
| Hypertriglyceridemia | 26-Jun-2015 | active |
| Type 2 diabetes mellitus | 20-Jun-2014 | active |
| Metabolic syndrome X | 20-Jun-2014 | active |
| Anemia | 02-Aug-1985 | active |
| Prediabetes | 27-Jul-1979 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Vitamin B12 5 MG/ML Injectable Solution | 1985-08-09 | - | 1 mL (5 mg) injected intramuscularly once weekly | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 16-Aug-2024 |
| SARS-CoV-2 mRNA vaccine | 12-Nov-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 30-Jul-2021 |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| Vaccine product containing only Clostridium tetani toxoid antigen adsorbed | ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Diabetes self management plan | 27-Jul-1979 | Prediabetes |
|
||
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2024-08-16 | 2023-08-11 |
|---|---|---|
| Body Height | 165.5 cm | 165.5 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
| Body Weight | 76.6 kg | 76.6 kg |
| Body mass index (BMI) [Ratio] | 28 kg/m2 | 28 kg/m2 |
| Diastolic Blood Pressure | 75 mm[Hg] | 76 mm[Hg] |
| Systolic Blood Pressure | 119 mm[Hg] | 126 mm[Hg] |
| Heart rate | 92 /min | 71 /min |
| Respiratory rate | 12 /min | 16 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 16-AUG-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 7.0 H | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 110.5 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 17.2 | 7 - 25 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 10.2 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 141.0 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 3.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 108.0 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 27.7 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 215.4 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 196.9 H | 35 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 128.7 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47.3 | 40 - 100 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 10.7 | 0 - 30 | mg/g |
Device Use
| Device | Date (since) |
|---|---|
| Blood glucose meter (physical object) | 27-Jul-1979 |